SG11201509750VA - Polymorph forms of icotinib maleate and uses thereof - Google Patents
Polymorph forms of icotinib maleate and uses thereofInfo
- Publication number
- SG11201509750VA SG11201509750VA SG11201509750VA SG11201509750VA SG11201509750VA SG 11201509750V A SG11201509750V A SG 11201509750VA SG 11201509750V A SG11201509750V A SG 11201509750VA SG 11201509750V A SG11201509750V A SG 11201509750VA SG 11201509750V A SG11201509750V A SG 11201509750VA
- Authority
- SG
- Singapore
- Prior art keywords
- polymorph forms
- icotinib maleate
- icotinib
- maleate
- polymorph
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/145—Maleic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013077093 | 2013-06-09 | ||
| PCT/CN2014/079484 WO2014198210A1 (en) | 2013-06-09 | 2014-06-09 | Polymorph forms of icotinib maleate and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201509750VA true SG11201509750VA (en) | 2015-12-30 |
Family
ID=52021656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201509750VA SG11201509750VA (en) | 2013-06-09 | 2014-06-09 | Polymorph forms of icotinib maleate and uses thereof |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9505774B2 (en) |
| EP (1) | EP3008070B9 (en) |
| JP (1) | JP6518655B2 (en) |
| KR (1) | KR102263410B1 (en) |
| AU (1) | AU2014280709B2 (en) |
| BR (1) | BR112015030591B1 (en) |
| CA (1) | CA2914854C (en) |
| ES (1) | ES2656699T3 (en) |
| RU (1) | RU2708079C9 (en) |
| SG (1) | SG11201509750VA (en) |
| TW (1) | TWI596098B (en) |
| WO (1) | WO2014198210A1 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20022332A3 (en) * | 2000-01-07 | 2003-01-15 | Transform Pharmaceuticals, Inc. | Sample assembly |
| US7078409B2 (en) * | 2002-03-28 | 2006-07-18 | Beta Pharma, Inc. | Fused quinazoline derivatives useful as tyrosine kinase inhibitors |
| AU2009267683B2 (en) * | 2008-07-08 | 2014-04-03 | Beta Pharma, Inc. | Icotinib hydrochloride, synthesis, crystallographic form, medical combination, and uses thereof |
| CA2854083C (en) * | 2011-10-31 | 2016-12-13 | Betta Pharmaceuticals Co., Ltd. | Methods of preparing icotinib and icotinib hydrochloride, and intermediates thereof |
-
2014
- 2014-06-09 BR BR112015030591-1A patent/BR112015030591B1/en active IP Right Grant
- 2014-06-09 CA CA2914854A patent/CA2914854C/en active Active
- 2014-06-09 ES ES14811414.3T patent/ES2656699T3/en active Active
- 2014-06-09 JP JP2016517155A patent/JP6518655B2/en active Active
- 2014-06-09 WO PCT/CN2014/079484 patent/WO2014198210A1/en active Application Filing
- 2014-06-09 TW TW103119971A patent/TWI596098B/en active
- 2014-06-09 US US14/896,707 patent/US9505774B2/en active Active
- 2014-06-09 EP EP14811414.3A patent/EP3008070B9/en active Active
- 2014-06-09 AU AU2014280709A patent/AU2014280709B2/en active Active
- 2014-06-09 RU RU2016100026A patent/RU2708079C9/en not_active Application Discontinuation
- 2014-06-09 SG SG11201509750VA patent/SG11201509750VA/en unknown
- 2014-06-09 KR KR1020167000369A patent/KR102263410B1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| JP6518655B2 (en) | 2019-05-22 |
| EP3008070A1 (en) | 2016-04-20 |
| EP3008070A4 (en) | 2016-08-10 |
| CA2914854A1 (en) | 2014-12-18 |
| US9505774B2 (en) | 2016-11-29 |
| TWI596098B (en) | 2017-08-21 |
| CA2914854C (en) | 2017-08-22 |
| WO2014198210A1 (en) | 2014-12-18 |
| EP3008070B1 (en) | 2017-11-15 |
| TW201512203A (en) | 2015-04-01 |
| JP2016520624A (en) | 2016-07-14 |
| AU2014280709A1 (en) | 2016-01-21 |
| RU2016100026A (en) | 2017-07-20 |
| KR20160018711A (en) | 2016-02-17 |
| BR112015030591B1 (en) | 2022-09-13 |
| ES2656699T3 (en) | 2018-02-28 |
| ES2656699T9 (en) | 2018-06-04 |
| US20160137658A1 (en) | 2016-05-19 |
| EP3008070B9 (en) | 2018-05-23 |
| KR102263410B1 (en) | 2021-06-10 |
| AU2014280709B2 (en) | 2017-05-04 |
| RU2708079C9 (en) | 2020-02-28 |
| RU2708079C2 (en) | 2019-12-04 |
| BR112015030591A2 (en) | 2017-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287516A (en) | Therapeutic uses of empagliflozin | |
| HRP20190101T1 (en) | Therapeutic uses of empagliflozin | |
| HK1213818A1 (en) | Therapeutic uses of empagliflozin | |
| HRP20181710T1 (en) | Use of benzimidazole-proline derivatives | |
| LT2981271T (en) | Therapeutic uses of empagliflozin | |
| IL244268A0 (en) | Heterocyclic compounds and methods of use | |
| HK1224307A1 (en) | Protoxin-ii variants and methods of use -ii | |
| HK1218388A1 (en) | Onapristone polymorphic forms and methods of use | |
| SG11201507389RA (en) | Integration of hydro-dechlorination and hydro-regeneration | |
| HK1207641A1 (en) | Polymorphic forms of icotinib and uses thereof | |
| ZA201508951B (en) | Polymorph forms of icotinib maleate and uses thereof | |
| EP2986627A4 (en) | INHIBITORS OF THE Eph-A RECEPTOR AND USES THEREOF | |
| HK1207644A1 (en) | Polymorph forms of icotinib maleate and uses thereof | |
| SG11201509750VA (en) | Polymorph forms of icotinib maleate and uses thereof | |
| PL3071575T3 (en) | Preparation of normorphinans | |
| HK1198422A1 (en) | Novel uses of colossolactones | |
| TWM476537U (en) | Structure of kettle |